nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—Cytochrome P450 3A4 Inhibitors—Cyclosporine—systemic lupus erythematosus	0.614	1	CiPCiCtD
Amprenavir—ABCC1—Cyclosporine—systemic lupus erythematosus	0.0242	0.0776	CbGbCtD
Amprenavir—CYP3A5—Dapsone—systemic lupus erythematosus	0.0136	0.0438	CbGbCtD
Amprenavir—CYP2C8—Dapsone—systemic lupus erythematosus	0.0131	0.0421	CbGbCtD
Amprenavir—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0128	0.0412	CbGbCtD
Amprenavir—ABCC1—Methotrexate—systemic lupus erythematosus	0.0128	0.041	CbGbCtD
Amprenavir—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0118	0.0379	CbGbCtD
Amprenavir—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0114	0.0365	CbGbCtD
Amprenavir—CYP2C19—Dapsone—systemic lupus erythematosus	0.011	0.0353	CbGbCtD
Amprenavir—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0101	0.0326	CbGbCtD
Amprenavir—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00948	0.0304	CbGbCtD
Amprenavir—CYP2C9—Dapsone—systemic lupus erythematosus	0.00914	0.0293	CbGbCtD
Amprenavir—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00912	0.0293	CbGbCtD
Amprenavir—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00896	0.0288	CbGbCtD
Amprenavir—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00861	0.0276	CbGbCtD
Amprenavir—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00769	0.0247	CbGbCtD
Amprenavir—CYP2C19—Prednisone—systemic lupus erythematosus	0.00762	0.0245	CbGbCtD
Amprenavir—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.00749	0.024	CbGbCtD
Amprenavir—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.00722	0.0232	CbGbCtD
Amprenavir—ABCB1—Betamethasone—systemic lupus erythematosus	0.0066	0.0212	CbGbCtD
Amprenavir—ABCB1—Prednisolone—systemic lupus erythematosus	0.00651	0.0209	CbGbCtD
Amprenavir—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00617	0.0198	CbGbCtD
Amprenavir—ABCB1—Prednisone—systemic lupus erythematosus	0.00615	0.0197	CbGbCtD
Amprenavir—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00608	0.0195	CbGbCtD
Amprenavir—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00601	0.0193	CbGbCtD
Amprenavir—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0059	0.0189	CbGbCtD
Amprenavir—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00583	0.0187	CbGbCtD
Amprenavir—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00567	0.0182	CbGbCtD
Amprenavir—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00549	0.0176	CbGbCtD
Amprenavir—CYP3A4—Dapsone—systemic lupus erythematosus	0.00531	0.0171	CbGbCtD
Amprenavir—CYP2C9—cardial valve—systemic lupus erythematosus	0.00512	0.266	CbGeAlD
Amprenavir—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00476	0.0153	CbGbCtD
Amprenavir—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00461	0.0148	CbGbCtD
Amprenavir—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00461	0.0148	CbGbCtD
Amprenavir—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00395	0.0127	CbGbCtD
Amprenavir—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00395	0.0127	CbGbCtD
Amprenavir—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0039	0.0125	CbGbCtD
Amprenavir—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00384	0.0123	CbGbCtD
Amprenavir—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0037	0.0119	CbGbCtD
Amprenavir—CYP3A4—Prednisone—systemic lupus erythematosus	0.00368	0.0118	CbGbCtD
Amprenavir—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00362	0.0116	CbGbCtD
Amprenavir—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00349	0.0112	CbGbCtD
Amprenavir—ABCB1—Methotrexate—systemic lupus erythematosus	0.00308	0.0099	CbGbCtD
Amprenavir—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0023	0.00738	CbGbCtD
Amprenavir—CYP2C19—urine—systemic lupus erythematosus	0.00142	0.074	CbGeAlD
Amprenavir—CYP2C9—urine—systemic lupus erythematosus	0.0011	0.0573	CbGeAlD
Amprenavir—CYP3A4—urine—systemic lupus erythematosus	0.000841	0.0437	CbGeAlD
Amprenavir—CYP2D6—urine—systemic lupus erythematosus	0.000828	0.043	CbGeAlD
Amprenavir—CYP2C19—blood plasma—systemic lupus erythematosus	0.000743	0.0386	CbGeAlD
Amprenavir—CYP2C8—blood plasma—systemic lupus erythematosus	0.000648	0.0337	CbGeAlD
Amprenavir—CYP3A5—blood plasma—systemic lupus erythematosus	0.000585	0.0304	CbGeAlD
Amprenavir—CYP2B6—blood plasma—systemic lupus erythematosus	0.000581	0.0302	CbGeAlD
Amprenavir—CYP2C9—blood plasma—systemic lupus erythematosus	0.000576	0.0299	CbGeAlD
Amprenavir—CYP3A4—blood plasma—systemic lupus erythematosus	0.000439	0.0228	CbGeAlD
Amprenavir—CYP2D6—blood plasma—systemic lupus erythematosus	0.000432	0.0225	CbGeAlD
Amprenavir—ABCC1—cortex of kidney—systemic lupus erythematosus	0.000336	0.0175	CbGeAlD
Amprenavir—ABCB1—blood plasma—systemic lupus erythematosus	0.000311	0.0162	CbGeAlD
Amprenavir—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000302	0.0157	CbGeAlD
Amprenavir—CYP2B6—nephron tubule—systemic lupus erythematosus	0.0003	0.0156	CbGeAlD
Amprenavir—CYP2C8—kidney—systemic lupus erythematosus	0.000294	0.0153	CbGeAlD
Amprenavir—CYP2B6—skin of body—systemic lupus erythematosus	0.00028	0.0145	CbGeAlD
Amprenavir—ABCC1—tendon—systemic lupus erythematosus	0.000279	0.0145	CbGeAlD
Amprenavir—CYP3A5—kidney—systemic lupus erythematosus	0.000265	0.0138	CbGeAlD
Amprenavir—CYP2B6—kidney—systemic lupus erythematosus	0.000264	0.0137	CbGeAlD
Amprenavir—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000258	0.0134	CbGeAlD
Amprenavir—ABCC1—lung—systemic lupus erythematosus	0.000245	0.0127	CbGeAlD
Amprenavir—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000226	0.0118	CbGeAlD
Amprenavir—CYP3A4—kidney—systemic lupus erythematosus	0.000199	0.0103	CbGeAlD
Amprenavir—CYP2D6—kidney—systemic lupus erythematosus	0.000196	0.0102	CbGeAlD
Amprenavir—CYP3A5—lung—systemic lupus erythematosus	0.000188	0.00977	CbGeAlD
Amprenavir—CYP2B6—lung—systemic lupus erythematosus	0.000187	0.00971	CbGeAlD
Amprenavir—CYP2B6—nervous system—systemic lupus erythematosus	0.000173	0.00899	CbGeAlD
Amprenavir—CYP2B6—central nervous system—systemic lupus erythematosus	0.000166	0.00865	CbGeAlD
Amprenavir—ABCB1—nephron tubule—systemic lupus erythematosus	0.00016	0.00833	CbGeAlD
Amprenavir—ABCB1—kidney—systemic lupus erythematosus	0.000141	0.00732	CbGeAlD
Amprenavir—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000137	0.00713	CbGeAlD
Amprenavir—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.000137	0.00247	CcSEcCtD
Amprenavir—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.000137	0.00247	CcSEcCtD
Amprenavir—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.000136	0.00246	CcSEcCtD
Amprenavir—Flatulence—Cyclosporine—systemic lupus erythematosus	0.000134	0.00242	CcSEcCtD
Amprenavir—Hyperglycaemia—Betamethasone—systemic lupus erythematosus	0.000134	0.00242	CcSEcCtD
Amprenavir—Hyperglycaemia—Dexamethasone—systemic lupus erythematosus	0.000134	0.00242	CcSEcCtD
Amprenavir—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00241	CcSEcCtD
Amprenavir—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.0024	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000132	0.00238	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000132	0.00238	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.000131	0.00237	CcSEcCtD
Amprenavir—Flatulence—Mycophenolate mofetil—systemic lupus erythematosus	0.000131	0.00236	CcSEcCtD
Amprenavir—CYP3A4—nervous system—systemic lupus erythematosus	0.000131	0.00679	CbGeAlD
Amprenavir—Acute coronary syndrome—Betamethasone—systemic lupus erythematosus	0.00013	0.00235	CcSEcCtD
Amprenavir—Acute coronary syndrome—Dexamethasone—systemic lupus erythematosus	0.00013	0.00235	CcSEcCtD
Amprenavir—Myocardial infarction—Dexamethasone—systemic lupus erythematosus	0.00013	0.00234	CcSEcCtD
Amprenavir—Myocardial infarction—Betamethasone—systemic lupus erythematosus	0.00013	0.00234	CcSEcCtD
Amprenavir—Paraesthesia—Leflunomide—systemic lupus erythematosus	0.000129	0.00233	CcSEcCtD
Amprenavir—CYP2D6—nervous system—systemic lupus erythematosus	0.000128	0.00668	CbGeAlD
Amprenavir—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.000128	0.00232	CcSEcCtD
Amprenavir—Tremor—Cyclosporine—systemic lupus erythematosus	0.000128	0.0023	CcSEcCtD
Amprenavir—CYP3A4—central nervous system—systemic lupus erythematosus	0.000126	0.00653	CbGeAlD
Amprenavir—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000125	0.00226	CcSEcCtD
Amprenavir—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000125	0.00225	CcSEcCtD
Amprenavir—Tremor—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.00225	CcSEcCtD
Amprenavir—Angioedema—Cyclosporine—systemic lupus erythematosus	0.000124	0.00225	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000124	0.00224	CcSEcCtD
Amprenavir—Fatigue—Leflunomide—systemic lupus erythematosus	0.000124	0.00224	CcSEcCtD
Amprenavir—CYP2D6—central nervous system—systemic lupus erythematosus	0.000124	0.00643	CbGeAlD
Amprenavir—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.000122	0.0022	CcSEcCtD
Amprenavir—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00219	CcSEcCtD
Amprenavir—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00219	CcSEcCtD
Amprenavir—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000121	0.00218	CcSEcCtD
Amprenavir—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000121	0.00629	CbGeAlD
Amprenavir—Neutropenia—Prednisone—systemic lupus erythematosus	0.000121	0.00218	CcSEcCtD
Amprenavir—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000121	0.00218	CcSEcCtD
Amprenavir—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000118	0.00213	CcSEcCtD
Amprenavir—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000117	0.0021	CcSEcCtD
Amprenavir—Myalgia—Cyclosporine—systemic lupus erythematosus	0.000116	0.00209	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—systemic lupus erythematosus	0.000115	0.00208	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000115	0.00208	CcSEcCtD
Amprenavir—Depression—Prednisone—systemic lupus erythematosus	0.000115	0.00207	CcSEcCtD
Amprenavir—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000115	0.00207	CcSEcCtD
Amprenavir—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00207	CcSEcCtD
Amprenavir—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000114	0.00205	CcSEcCtD
Amprenavir—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00205	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisone—systemic lupus erythematosus	0.000114	0.00205	CcSEcCtD
Amprenavir—Angioedema—Prednisolone—systemic lupus erythematosus	0.000113	0.00204	CcSEcCtD
Amprenavir—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000113	0.00204	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisone—systemic lupus erythematosus	0.000113	0.00204	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000112	0.00203	CcSEcCtD
Amprenavir—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000112	0.00202	CcSEcCtD
Amprenavir—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000111	0.002	CcSEcCtD
Amprenavir—ABCB1—bone marrow—systemic lupus erythematosus	0.00011	0.00573	CbGeAlD
Amprenavir—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000109	0.00197	CcSEcCtD
Amprenavir—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000108	0.00195	CcSEcCtD
Amprenavir—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.00192	CcSEcCtD
Amprenavir—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000106	0.00191	CcSEcCtD
Amprenavir—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.0019	CcSEcCtD
Amprenavir—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000104	0.00188	CcSEcCtD
Amprenavir—Discomfort—Prednisolone—systemic lupus erythematosus	0.000104	0.00188	CcSEcCtD
Amprenavir—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000104	0.00188	CcSEcCtD
Amprenavir—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000104	0.00187	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000104	0.00187	CcSEcCtD
Amprenavir—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.00186	CcSEcCtD
Amprenavir—Asthenia—Leflunomide—systemic lupus erythematosus	0.000103	0.00186	CcSEcCtD
Amprenavir—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000103	0.00186	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000102	0.00185	CcSEcCtD
Amprenavir—Pruritus—Leflunomide—systemic lupus erythematosus	0.000102	0.00184	CcSEcCtD
Amprenavir—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000102	0.00184	CcSEcCtD
Amprenavir—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000102	0.00183	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000101	0.00183	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000101	0.00182	CcSEcCtD
Amprenavir—Paraesthesia—Cyclosporine—systemic lupus erythematosus	9.98e-05	0.0018	CcSEcCtD
Amprenavir—ABCB1—lung—systemic lupus erythematosus	9.98e-05	0.00519	CbGeAlD
Amprenavir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	9.88e-05	0.00178	CcSEcCtD
Amprenavir—Diarrhoea—Leflunomide—systemic lupus erythematosus	9.86e-05	0.00178	CcSEcCtD
Amprenavir—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	9.74e-05	0.00176	CcSEcCtD
Amprenavir—Myalgia—Triamcinolone—systemic lupus erythematosus	9.7e-05	0.00175	CcSEcCtD
Amprenavir—Vomiting—Azathioprine—systemic lupus erythematosus	9.7e-05	0.00175	CcSEcCtD
Amprenavir—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	9.69e-05	0.00175	CcSEcCtD
Amprenavir—Myalgia—Methylprednisolone—systemic lupus erythematosus	9.68e-05	0.00175	CcSEcCtD
Amprenavir—Decreased appetite—Cyclosporine—systemic lupus erythematosus	9.66e-05	0.00174	CcSEcCtD
Amprenavir—Rash—Azathioprine—systemic lupus erythematosus	9.62e-05	0.00174	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	9.62e-05	0.00173	CcSEcCtD
Amprenavir—Dermatitis—Azathioprine—systemic lupus erythematosus	9.61e-05	0.00173	CcSEcCtD
Amprenavir—Depression—Methotrexate—systemic lupus erythematosus	9.6e-05	0.00173	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	9.6e-05	0.00173	CcSEcCtD
Amprenavir—Skin disorder—Hydrocortisone—systemic lupus erythematosus	9.6e-05	0.00173	CcSEcCtD
Amprenavir—Discomfort—Triamcinolone—systemic lupus erythematosus	9.59e-05	0.00173	CcSEcCtD
Amprenavir—Fatigue—Cyclosporine—systemic lupus erythematosus	9.58e-05	0.00173	CcSEcCtD
Amprenavir—Discomfort—Methylprednisolone—systemic lupus erythematosus	9.57e-05	0.00173	CcSEcCtD
Amprenavir—Headache—Azathioprine—systemic lupus erythematosus	9.56e-05	0.00172	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	9.55e-05	0.00172	CcSEcCtD
Amprenavir—Angioedema—Dexamethasone—systemic lupus erythematosus	9.45e-05	0.0017	CcSEcCtD
Amprenavir—Angioedema—Betamethasone—systemic lupus erythematosus	9.45e-05	0.0017	CcSEcCtD
Amprenavir—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	9.43e-05	0.0017	CcSEcCtD
Amprenavir—Anorexia—Hydrocortisone—systemic lupus erythematosus	9.42e-05	0.0017	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	9.36e-05	0.00169	CcSEcCtD
Amprenavir—ABCB1—nervous system—systemic lupus erythematosus	9.24e-05	0.0048	CbGeAlD
Amprenavir—Vomiting—Leflunomide—systemic lupus erythematosus	9.16e-05	0.00165	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	9.11e-05	0.00164	CcSEcCtD
Amprenavir—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	9.1e-05	0.00164	CcSEcCtD
Amprenavir—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	9.09e-05	0.00164	CcSEcCtD
Amprenavir—Paraesthesia—Prednisolone—systemic lupus erythematosus	9.08e-05	0.00164	CcSEcCtD
Amprenavir—Rash—Leflunomide—systemic lupus erythematosus	9.08e-05	0.00164	CcSEcCtD
Amprenavir—Dermatitis—Leflunomide—systemic lupus erythematosus	9.07e-05	0.00164	CcSEcCtD
Amprenavir—Mental disorder—Prednisone—systemic lupus erythematosus	9.06e-05	0.00164	CcSEcCtD
Amprenavir—Nausea—Azathioprine—systemic lupus erythematosus	9.06e-05	0.00163	CcSEcCtD
Amprenavir—Headache—Leflunomide—systemic lupus erythematosus	9.02e-05	0.00163	CcSEcCtD
Amprenavir—Skin disorder—Methylprednisolone—systemic lupus erythematosus	9.02e-05	0.00163	CcSEcCtD
Amprenavir—Malnutrition—Prednisone—systemic lupus erythematosus	9.01e-05	0.00162	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	9e-05	0.00162	CcSEcCtD
Amprenavir—ABCB1—central nervous system—systemic lupus erythematosus	8.9e-05	0.00463	CbGeAlD
Amprenavir—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	8.87e-05	0.0016	CcSEcCtD
Amprenavir—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	8.87e-05	0.0016	CcSEcCtD
Amprenavir—Myalgia—Dexamethasone—systemic lupus erythematosus	8.8e-05	0.00159	CcSEcCtD
Amprenavir—Myalgia—Betamethasone—systemic lupus erythematosus	8.8e-05	0.00159	CcSEcCtD
Amprenavir—Abdominal pain—Cyclosporine—systemic lupus erythematosus	8.79e-05	0.00159	CcSEcCtD
Amprenavir—Discomfort—Dexamethasone—systemic lupus erythematosus	8.7e-05	0.00157	CcSEcCtD
Amprenavir—Discomfort—Betamethasone—systemic lupus erythematosus	8.7e-05	0.00157	CcSEcCtD
Amprenavir—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	8.59e-05	0.00155	CcSEcCtD
Amprenavir—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	8.57e-05	0.00155	CcSEcCtD
Amprenavir—Nausea—Leflunomide—systemic lupus erythematosus	8.56e-05	0.00154	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	8.53e-05	0.00154	CcSEcCtD
Amprenavir—Fatigue—Hydrocortisone—systemic lupus erythematosus	8.52e-05	0.00154	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	8.48e-05	0.00153	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	8.46e-05	0.00153	CcSEcCtD
Amprenavir—Paraesthesia—Triamcinolone—systemic lupus erythematosus	8.35e-05	0.00151	CcSEcCtD
Amprenavir—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	8.33e-05	0.0015	CcSEcCtD
Amprenavir—Nervous system disorder—Betamethasone—systemic lupus erythematosus	8.28e-05	0.00149	CcSEcCtD
Amprenavir—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	8.28e-05	0.00149	CcSEcCtD
Amprenavir—Angioedema—Prednisone—systemic lupus erythematosus	8.23e-05	0.00148	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—systemic lupus erythematosus	8.18e-05	0.00148	CcSEcCtD
Amprenavir—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	8.08e-05	0.00146	CcSEcCtD
Amprenavir—Anorexia—Betamethasone—systemic lupus erythematosus	8.05e-05	0.00145	CcSEcCtD
Amprenavir—Anorexia—Dexamethasone—systemic lupus erythematosus	8.05e-05	0.00145	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—systemic lupus erythematosus	8.02e-05	0.00145	CcSEcCtD
Amprenavir—Fatigue—Triamcinolone—systemic lupus erythematosus	8.02e-05	0.00145	CcSEcCtD
Amprenavir—Fatigue—Methylprednisolone—systemic lupus erythematosus	8e-05	0.00144	CcSEcCtD
Amprenavir—Asthenia—Cyclosporine—systemic lupus erythematosus	7.98e-05	0.00144	CcSEcCtD
Amprenavir—Pruritus—Cyclosporine—systemic lupus erythematosus	7.86e-05	0.00142	CcSEcCtD
Amprenavir—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	7.81e-05	0.00141	CcSEcCtD
Amprenavir—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	7.78e-05	0.0014	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	7.69e-05	0.00139	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	7.69e-05	0.00139	CcSEcCtD
Amprenavir—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	7.67e-05	0.00138	CcSEcCtD
Amprenavir—Myalgia—Prednisone—systemic lupus erythematosus	7.67e-05	0.00138	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	7.62e-05	0.00137	CcSEcCtD
Amprenavir—Diarrhoea—Cyclosporine—systemic lupus erythematosus	7.61e-05	0.00137	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	7.59e-05	0.00137	CcSEcCtD
Amprenavir—Paraesthesia—Betamethasone—systemic lupus erythematosus	7.58e-05	0.00137	CcSEcCtD
Amprenavir—Paraesthesia—Dexamethasone—systemic lupus erythematosus	7.58e-05	0.00137	CcSEcCtD
Amprenavir—Discomfort—Prednisone—systemic lupus erythematosus	7.58e-05	0.00137	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—systemic lupus erythematosus	7.58e-05	0.00137	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—systemic lupus erythematosus	7.53e-05	0.00136	CcSEcCtD
Amprenavir—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	7.42e-05	0.00134	CcSEcCtD
Amprenavir—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	7.34e-05	0.00132	CcSEcCtD
Amprenavir—Decreased appetite—Dexamethasone—systemic lupus erythematosus	7.34e-05	0.00132	CcSEcCtD
Amprenavir—Decreased appetite—Betamethasone—systemic lupus erythematosus	7.34e-05	0.00132	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	7.29e-05	0.00131	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	7.29e-05	0.00131	CcSEcCtD
Amprenavir—Fatigue—Betamethasone—systemic lupus erythematosus	7.28e-05	0.00131	CcSEcCtD
Amprenavir—Fatigue—Dexamethasone—systemic lupus erythematosus	7.28e-05	0.00131	CcSEcCtD
Amprenavir—Nervous system disorder—Prednisone—systemic lupus erythematosus	7.21e-05	0.0013	CcSEcCtD
Amprenavir—Skin disorder—Prednisone—systemic lupus erythematosus	7.14e-05	0.00129	CcSEcCtD
Amprenavir—Asthenia—Hydrocortisone—systemic lupus erythematosus	7.09e-05	0.00128	CcSEcCtD
Amprenavir—Vomiting—Cyclosporine—systemic lupus erythematosus	7.07e-05	0.00128	CcSEcCtD
Amprenavir—Rash—Cyclosporine—systemic lupus erythematosus	7.01e-05	0.00126	CcSEcCtD
Amprenavir—Anorexia—Prednisone—systemic lupus erythematosus	7.01e-05	0.00126	CcSEcCtD
Amprenavir—Dermatitis—Cyclosporine—systemic lupus erythematosus	7e-05	0.00126	CcSEcCtD
Amprenavir—Pruritus—Hydrocortisone—systemic lupus erythematosus	6.99e-05	0.00126	CcSEcCtD
Amprenavir—Headache—Cyclosporine—systemic lupus erythematosus	6.96e-05	0.00126	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	6.9e-05	0.00125	CcSEcCtD
Amprenavir—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	6.9e-05	0.00125	CcSEcCtD
Amprenavir—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	6.89e-05	0.00124	CcSEcCtD
Amprenavir—Rash—Mycophenolate mofetil—systemic lupus erythematosus	6.84e-05	0.00123	CcSEcCtD
Amprenavir—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	6.83e-05	0.00123	CcSEcCtD
Amprenavir—Headache—Mycophenolate mofetil—systemic lupus erythematosus	6.79e-05	0.00123	CcSEcCtD
Amprenavir—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	6.76e-05	0.00122	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	6.7e-05	0.00121	CcSEcCtD
Amprenavir—Asthenia—Triamcinolone—systemic lupus erythematosus	6.67e-05	0.0012	CcSEcCtD
Amprenavir—Abdominal pain—Betamethasone—systemic lupus erythematosus	6.67e-05	0.0012	CcSEcCtD
Amprenavir—Abdominal pain—Dexamethasone—systemic lupus erythematosus	6.67e-05	0.0012	CcSEcCtD
Amprenavir—Asthenia—Methylprednisolone—systemic lupus erythematosus	6.66e-05	0.0012	CcSEcCtD
Amprenavir—Nausea—Cyclosporine—systemic lupus erythematosus	6.6e-05	0.00119	CcSEcCtD
Amprenavir—Paraesthesia—Prednisone—systemic lupus erythematosus	6.6e-05	0.00119	CcSEcCtD
Amprenavir—Pruritus—Triamcinolone—systemic lupus erythematosus	6.58e-05	0.00119	CcSEcCtD
Amprenavir—Pruritus—Methylprednisolone—systemic lupus erythematosus	6.57e-05	0.00118	CcSEcCtD
Amprenavir—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	6.44e-05	0.00116	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—systemic lupus erythematosus	6.41e-05	0.00116	CcSEcCtD
Amprenavir—Decreased appetite—Prednisone—systemic lupus erythematosus	6.39e-05	0.00115	CcSEcCtD
Amprenavir—Rash—Prednisolone—systemic lupus erythematosus	6.38e-05	0.00115	CcSEcCtD
Amprenavir—Dermatitis—Prednisolone—systemic lupus erythematosus	6.37e-05	0.00115	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	6.36e-05	0.00115	CcSEcCtD
Amprenavir—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	6.35e-05	0.00115	CcSEcCtD
Amprenavir—Fatigue—Prednisone—systemic lupus erythematosus	6.34e-05	0.00114	CcSEcCtD
Amprenavir—Headache—Prednisolone—systemic lupus erythematosus	6.34e-05	0.00114	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—systemic lupus erythematosus	6.33e-05	0.00114	CcSEcCtD
Amprenavir—Vomiting—Hydrocortisone—systemic lupus erythematosus	6.28e-05	0.00113	CcSEcCtD
Amprenavir—Rash—Hydrocortisone—systemic lupus erythematosus	6.23e-05	0.00112	CcSEcCtD
Amprenavir—Dermatitis—Hydrocortisone—systemic lupus erythematosus	6.22e-05	0.00112	CcSEcCtD
Amprenavir—Headache—Hydrocortisone—systemic lupus erythematosus	6.19e-05	0.00112	CcSEcCtD
Amprenavir—Asthenia—Betamethasone—systemic lupus erythematosus	6.06e-05	0.00109	CcSEcCtD
Amprenavir—Asthenia—Dexamethasone—systemic lupus erythematosus	6.06e-05	0.00109	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—systemic lupus erythematosus	6.02e-05	0.00109	CcSEcCtD
Amprenavir—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	6.01e-05	0.00108	CcSEcCtD
Amprenavir—Nausea—Prednisolone—systemic lupus erythematosus	6.01e-05	0.00108	CcSEcCtD
Amprenavir—Pruritus—Dexamethasone—systemic lupus erythematosus	5.97e-05	0.00108	CcSEcCtD
Amprenavir—Pruritus—Betamethasone—systemic lupus erythematosus	5.97e-05	0.00108	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—systemic lupus erythematosus	5.97e-05	0.00108	CcSEcCtD
Amprenavir—Vomiting—Triamcinolone—systemic lupus erythematosus	5.91e-05	0.00107	CcSEcCtD
Amprenavir—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.9e-05	0.00106	CcSEcCtD
Amprenavir—Nausea—Hydrocortisone—systemic lupus erythematosus	5.87e-05	0.00106	CcSEcCtD
Amprenavir—Rash—Triamcinolone—systemic lupus erythematosus	5.87e-05	0.00106	CcSEcCtD
Amprenavir—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.86e-05	0.00106	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—systemic lupus erythematosus	5.86e-05	0.00106	CcSEcCtD
Amprenavir—Rash—Methylprednisolone—systemic lupus erythematosus	5.85e-05	0.00106	CcSEcCtD
Amprenavir—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.85e-05	0.00105	CcSEcCtD
Amprenavir—Headache—Triamcinolone—systemic lupus erythematosus	5.83e-05	0.00105	CcSEcCtD
Amprenavir—Headache—Methylprednisolone—systemic lupus erythematosus	5.81e-05	0.00105	CcSEcCtD
Amprenavir—Abdominal pain—Prednisone—systemic lupus erythematosus	5.81e-05	0.00105	CcSEcCtD
Amprenavir—Diarrhoea—Dexamethasone—systemic lupus erythematosus	5.78e-05	0.00104	CcSEcCtD
Amprenavir—Diarrhoea—Betamethasone—systemic lupus erythematosus	5.78e-05	0.00104	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	5.6e-05	0.00101	CcSEcCtD
Amprenavir—Nausea—Triamcinolone—systemic lupus erythematosus	5.53e-05	0.000997	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—systemic lupus erythematosus	5.52e-05	0.000995	CcSEcCtD
Amprenavir—Nausea—Methylprednisolone—systemic lupus erythematosus	5.51e-05	0.000995	CcSEcCtD
Amprenavir—Vomiting—Dexamethasone—systemic lupus erythematosus	5.37e-05	0.000968	CcSEcCtD
Amprenavir—Vomiting—Betamethasone—systemic lupus erythematosus	5.37e-05	0.000968	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—systemic lupus erythematosus	5.34e-05	0.000963	CcSEcCtD
Amprenavir—Rash—Betamethasone—systemic lupus erythematosus	5.32e-05	0.00096	CcSEcCtD
Amprenavir—Rash—Dexamethasone—systemic lupus erythematosus	5.32e-05	0.00096	CcSEcCtD
Amprenavir—Dermatitis—Dexamethasone—systemic lupus erythematosus	5.32e-05	0.000959	CcSEcCtD
Amprenavir—Dermatitis—Betamethasone—systemic lupus erythematosus	5.32e-05	0.000959	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	5.3e-05	0.000957	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—systemic lupus erythematosus	5.3e-05	0.000956	CcSEcCtD
Amprenavir—Headache—Betamethasone—systemic lupus erythematosus	5.29e-05	0.000954	CcSEcCtD
Amprenavir—Headache—Dexamethasone—systemic lupus erythematosus	5.29e-05	0.000954	CcSEcCtD
Amprenavir—Asthenia—Prednisone—systemic lupus erythematosus	5.27e-05	0.000952	CcSEcCtD
Amprenavir—Pruritus—Prednisone—systemic lupus erythematosus	5.2e-05	0.000938	CcSEcCtD
Amprenavir—Diarrhoea—Prednisone—systemic lupus erythematosus	5.03e-05	0.000907	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	5.02e-05	0.000906	CcSEcCtD
Amprenavir—Nausea—Dexamethasone—systemic lupus erythematosus	5.01e-05	0.000905	CcSEcCtD
Amprenavir—Nausea—Betamethasone—systemic lupus erythematosus	5.01e-05	0.000905	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—systemic lupus erythematosus	4.86e-05	0.000876	CcSEcCtD
Amprenavir—Vomiting—Prednisone—systemic lupus erythematosus	4.67e-05	0.000843	CcSEcCtD
Amprenavir—Rash—Prednisone—systemic lupus erythematosus	4.63e-05	0.000836	CcSEcCtD
Amprenavir—Dermatitis—Prednisone—systemic lupus erythematosus	4.63e-05	0.000835	CcSEcCtD
Amprenavir—Headache—Prednisone—systemic lupus erythematosus	4.6e-05	0.000831	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—systemic lupus erythematosus	4.41e-05	0.000795	CcSEcCtD
Amprenavir—Nausea—Prednisone—systemic lupus erythematosus	4.37e-05	0.000788	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—systemic lupus erythematosus	4.35e-05	0.000784	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—systemic lupus erythematosus	4.2e-05	0.000758	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—systemic lupus erythematosus	3.91e-05	0.000705	CcSEcCtD
Amprenavir—Rash—Methotrexate—systemic lupus erythematosus	3.87e-05	0.000699	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—systemic lupus erythematosus	3.87e-05	0.000698	CcSEcCtD
Amprenavir—Headache—Methotrexate—systemic lupus erythematosus	3.85e-05	0.000694	CcSEcCtD
Amprenavir—Nausea—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000658	CcSEcCtD
